Sex-related differences in bronchial epithelial changes associated with tobacco smoking

Journal of the National Cancer Institute

Volumn 91, Issue 8, 1999, Pages 691-696

  Lam, Stephen ^c   LeRiche, Jean C ^d   Zheng, Yvonne ^d   Coldman, Andrew ^d   MacAulay, Calum ^d   Hawk, Ernest ^a   Kelloff, Gary ^a   Gazdar, Adi F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CANCER RISK; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TOBACCO;

EID: 0033590963     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.8.691     Document Type: Article

References (39)

1. Villeneuve PJ, Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health 1994;85:385-8.
2. Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs 1970-1977. N Engl J Med 1979;300:381-5.
3. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer 1996;78:1004-10.
4. Gazdar AF, Minna JD. Cigarettes, sex, and lung adenocarcinoma [editorial]. J Natl Cancer Inst 1997;89:1563-5.
5. Lam S, MacAulay C, Hung J, leRiche J, Profio AE, Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993;105:1035-40.
6. Lam S, MacAulay C, leRiche JC, Ikeda N, Palcic B. Early localization of bronchogenic carcinoma. Diagnostic and Therapeutic Endoscopy 1994;1: 75-8.
7. Lam S, Kennedy T, Unger M, Miller YE, Gelmont D, Rusch V, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998;113:696-702.
8. Langone JJ, Gjika HB, Van Vunakis H. Nicotine and its metabolites. Radioimmunoassay for nicotine and cotinine. Biochemistry 1973;12:5025-30.
9. Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RG, Van Vunakis H, et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992;145:1129-35.
10. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
11. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
12. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70.
13. Risse EK, Vooijs GP, van't Hof MA. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta Cytol 1988;32:629-34.
14. Frost JK, Ball WC Jr, Levin ML, Tockman MS. Erozan YS, Gupta PK, et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med 1986;28:692-703.
15. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-6.
16. Travis WD, Travis LB, Devesa SS. Lung cancer [published erratum appears in Cancer 1995;75:2979]. Cancer 1995;75(1 Suppl):191-202.
17. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88: 183-92.
18. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3.
19. Dahl AR, Gerde P. Uptake and metabolism of toxicants in the respiratory tract. Environ Health Perspect 1994;102(Suppl 11):67-70.
20. Forkert PG. CYP2EI is preferentially expressed in Clara cells in murine lung: localization by in situ hybridization and immunohistochemical methods. Am J Respir Cell Mol Biol 1995;12:589-96.
21. Kurie JM, Lee JS, Morice RC, Walsh GL, Khuri FR, Broxson A, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1998;90: 991-5.
22. O'Neil KM, Johnson BE. Lights flicker on fluorescence bronchoscopy in patients at risk for lung cancer [editorial]. J Natl Cancer Inst 1998;90: 953-5.
23. Lam S, Palcic B. Re: Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers [letter]. J Natl Cancer Inst 1999;91:561-2.
24. Vermylen P, Roufosse C, Pierard P, Verhest A, Sculier JP, Ninane V. Detection of preneoplastic lesions with fluorescence bronchoscopy (FB). Eur Respir J 1997;10:425S.
25. Yokomise H, Yanagihara K, Fukuse T, Hirata T, Ike O, Mizuno H, et al. Clinical experience of lung imaging fluorescence endoscope (LIFE) on lung cancer patients. J Bronchol 1997;4:205-8.
26. Ikeda N, Kim K, Okunaka T, Furukawa K, Furuya T, Saito M, et al. Early localization of bronchogenic cancerous/precancerous lesions with lung imaging fluorescence endoscope. Diagnostic and Therapeutic Endoscopy 1997;3:197-201.
27. Khanavkar B, Gnudi F, Muti A, Muller KM, Atay Z, Nakhosteen JA. Grundlagen der Autofluoreszenzbronchoskopie. Pneumologie 1998;52: 71-6.
28. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987;106: 512-8.
29. Kuller LH, Ockene J, Meilahn E, Svendsen KH. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol 1990;132: 265-74.
30. Nomura A, Stemmermann GN, Chyou PH, Marcus EB, Buist AS. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991;144:307-11.
31. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986;105:503-7.
32. Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, et al. The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992;145:301-10.
33. Burrows B, Knudson RJ, Camilli AE, Lyle SK, Lebowitz MD. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 1987;135: 788-93.
34. Kennedy TC, Proudfoot SP, Franklin WA, Merrick TA, Saccomanno G, Corkill ME, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 1996;56: 4673-8.
35. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85: 457-64.
36. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, leRiche JC, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-73.
37. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
38. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1954;6:963-8.
39. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-7.